Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal differences affect male pattern baldness.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Skin health and diseases are closely linked to metabolic processes.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Injecting cosyntropin into grizzly bears increases blood cortisol but doesn't change hair cortisol levels.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Insulin resistance and nesfatin-1 are linked to acne severity.

Ancient hair can preserve hormones, revealing health and fertility insights.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

The dog likely has a condition similar to Canine alopecia X.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.